Remdesivir

COVID: AIIMS Study on Children

The All India Institute of Medical Sciences, AIIMS recently conducted a study on children suffering from COVID-19. According to the study, adolescents suffered from lower mortality and lesser symptoms as compared to the adults. Key findings 1% of the adolescents ..

Month: 

Category: 

Government to discontinue Central Allocation of Remdesivir

According to Minister of State for Chemicals and Fertilizers, Shri Mansukh Mandaviya, government has decided to discontinue Central Allocation of Remdesivir to States and directed National Pharmaceuticals Pricing Agency to monitor availability of Remdesivir in India. Highlights Minister highlights, production ..

Month: 

26th Meeting of Group of Ministers on COVID-19

On May 17, 20121, the Union Minister of Health and Family Welfare chaired the 26th meeting of Group of Ministers on COVID-19. Key Outcomes of the meet CoWIN portal is to be made available in Hindi. Also, it will be ..

Month: 

US Global Task Force on COVID-19

The External Affairs Minister of India recently held a discussion with the US Global Task Force on Pandemic Response. He discussed about the priorities of India in vaccines, pharmaceuticals and oxygen. The Global Task Force on Pandemic earlier announced that ..

Month: 

0% IGST on Import of Covid-related relief material

The Government of India recently waived the Integrated GST till June 30, 2021. This included Remdesivir, Beta cyclodextrin, medical grade oxygen, oxygen concentrators, cryogenic transport tanks, etc. Conditions The Government of India has provided exemptions under the following conditions: A ..

Month: 

AAYUDH Advance Controversy

In April 2021, it was claimed that a drug called Aayudh Advance was effective against COVID-19. The trials for the drug were conducted at two government hospitals in Ahmedabad. However, Government of India has recently rejected the claims made by ..

Month: 

Remdesivir Shortage in India

Remdesivir is an injectable anti-virus. It is injected to prevent replication of the virus. The Remdesivir was created in 2014. It was manufactured in large scale to treat Ebola. Later it was used to treat SARS and MERS. Recently, after ..

Month: 

What is Emergency Use Authorization?

Recently, several drug makers are seeking Emergency Use Authorisation (EUA) for the COVID-19 vaccine. Pfizer had applied for the EUA in UK and has been approved by the Medicines and Healthcare Products Regulatory Agency of the country. Also, the Serum ..

Month: